Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REG1 anticoagulation system versus heparin in acute coronary syndrome
2009-012803-24Phase 2Terminated
- Sponsor
- Regado Biosciences
- Start
- Jul 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, RNA Aptamers → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of pegnivacogin, Anivamersen and heparin in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by Regado Biosciences. Started Jul 2009; status: terminated.
02
Drugs
pegnivacoginAnivamersenheparin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-012803-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012803-24.